Cosegregation and functional analysis of mutant ABCR (ABCA4) alleles in families that manifest both Stargardt disease and age-related macular degeneration
NF Shroyer, RA Lewis, A N. Yatsenko… - Human molecular …, 2001 - academic.oup.com
Human molecular genetics, 2001•academic.oup.com
Mutations in ABCR (ABCA4) have been reported to cause a spectrum of autosomal
recessively inherited retinopathies, including Stargardt disease (STGD), cone–rod dystrophy
and retinitis pigmentosa. Individuals heterozygous for ABCR mutations may be predisposed
to develop the multifactorial disorder age-related macular degeneration (AMD). We
hypothesized that some carriers of STGD alleles have an increased risk to develop AMD.
We tested this hypothesis in a cohort of families that manifest both STGD and AMD. With a …
recessively inherited retinopathies, including Stargardt disease (STGD), cone–rod dystrophy
and retinitis pigmentosa. Individuals heterozygous for ABCR mutations may be predisposed
to develop the multifactorial disorder age-related macular degeneration (AMD). We
hypothesized that some carriers of STGD alleles have an increased risk to develop AMD.
We tested this hypothesis in a cohort of families that manifest both STGD and AMD. With a …
Abstract
Mutations in ABCR (ABCA4) have been reported to cause a spectrum of autosomal recessively inherited retinopathies, including Stargardt disease (STGD), cone–rod dystrophy and retinitis pigmentosa. Individuals heterozygous for ABCR mutations may be predisposed to develop the multifactorial disorder age-related macular degeneration (AMD). We hypothesized that some carriers of STGD alleles have an increased risk to develop AMD. We tested this hypothesis in a cohort of families that manifest both STGD and AMD. With a direct-sequencing mutation detection strategy, we found that AMD-affected relatives of STGD patients are more likely to be carriers of pathogenic STGD alleles than predicted based on chance alone. We further investigated the role of AMD-associated ABCR mutations by testing for expression and ATP-binding defects in an in vitro biochemical assay. We found that mutations associated with AMD have a range of assayable defects ranging from no detectable defect to apparent null alleles. Of the 21 missense ABCR mutations reported in patients with AMD, 16 (76%) show abnormalities in protein expression, ATP-binding or ATPase activity. We infer that carrier relatives of STGD patients are predisposed to develop AMD.
